Samuel Abbate
Endocrinology, Diabetes & Metabolism · Wasilla, AKNPI 1316953409
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $825 and has fallen 60.3% since, to $327 in 2021.
Across 112 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$307
- Lilly USA, LLC$290
- Novo Nordisk$213
- Amgen$184
- Merck$152
- Sanofi-aventis U.S. LLC$147
- plus $459 from 15 others
What the payments were for
- Food & beverage$1,72598%
- Education$272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 20 | $307 |
| Lilly USA, LLC | 19 | $290 |
| Novo Nordisk | 14 | $213 |
| Amgen | 11 | $184 |
| Merck | 10 | $152 |
| Sanofi-aventis U.S. LLC | 9 | $147 |
| AbbVie(2 entities) | 8 | $118 |
| Amarin Pharma, Inc. | 5 | $90 |
| IBSA Pharma Inc. | 2 | $36 |
| Radius Health, Inc. | 2 | $34 |
| Dexcom, Inc. | 2 | $32 |
| Medtronic | 1 | $19 |
| Pfizer | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Abbott | 1 | $14 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Aegerion Pharmaceuticals, Inc. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
How this compares
Too few endocrinology, diabetes & metabolism providers in Alaskato place this figure against a meaningful peer group, so we don't.
Other endocrinology, diabetes & metabolism in Wasilla
- Jerry TannerAnchorage$18K
- Jeffrey MedlandAnchorage$9K
- Janice KovalAnchorage$6K
- Jeanne BonarAnchorage$2K
- Muhammad AhmedFairbanks$1K
- Konrad KaltenbornAnchorage$1K
- Patrick NolanAnchorage$986
- Laily MahooziCordova$83
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.